key: cord-0808604-aue1ewo3
authors: Mulka, Kathleen R.; Beck, Sarah E.; Solis, Clarisse V.; Johanson, Andrew L.; Queen, Suzanne E.; McCarron, Megan E.; Richardson, Morgan R.; Zhou, Ruifeng; Marinho, Paula; Jedlicka, Anne; Guerrero-Martin, Selena; Shirk, Erin N.; Braxton, Alicia M.; Brockhurst, Jacqueline; Creisher, Patrick S.; Dhakal, Santosh; Brayton, Cory F.; Veenhuis, Rebecca T.; Metcalf Pate, Kelly A.; Karakousis, Petros C.; Zahnow, Cynthia A.; Klein, Sabra L.; Jain, Sanjay K.; Tarwater, Patrick M.; Pekosz, Andrew S.; Villano, Jason S.; Mankowski, Joseph L.
title: Progression and Resolution of SARS-CoV-2 Infection in Golden Syrian Hamsters
date: 2021-11-10
journal: Am J Pathol
DOI: 10.1016/j.ajpath.2021.10.009
sha: 53ab5eda199acca48cfa44e39bf61fde18d4942a
doc_id: 808604
cord_uid: aue1ewo3

To catalyze SARS-CoV-2 research including development of novel interventive and preventive strategies, we characterized progression of disease in depth in a robust COVID-19 animal model. In this model, male and female golden Syrian hamsters were inoculated intranasally with SARS-CoV-2 USA-WA1/2020. Groups of inoculated and mock-inoculated uninfected control animals were euthanized at 2, 4, 7, 14 and 28 days post-inoculation to track multiple clinical, pathology, virology, and immunology outcomes. SARS-CoV-2-inoculated animals consistently lost body weight during the first week of infection, had higher lung weights at terminal timepoints, and developed lung consolidation per histopathology and quantitative image analysis measurements. High levels of infectious virus and viral RNA were reliably present in the respiratory tract at days 2 and 4 post-inoculation, corresponding with widespread necrosis and inflammation. At day 7, when infectious virus was rare, interstitial and alveolar macrophage infiltrates and marked reparative epithelial responses (type II hyperplasia) dominated in the lung. These lesions resolved over time, with only residual epithelial repair evident by day 28 post-inoculation. The use of quantitative approaches to measure cellular and morphologic alterations in the lung provides valuable outcome measures for developing therapeutic and preventive interventions for COVID-19 using the hamster COVID-19 model.

In December 2019, a novel beta coronavirus was isolated from patients that presented with severe and ultimately fatal pneumonia in Wuhan, China 1 While many organ systems can be affected by SARS-CoV-2 infection, pulmonary disease has been most frequently associated with severe and fatal cases of COVID-19 2 . The earliest stage of disease is characterized by edema and vascular damage including endothelial cell degeneration and necrosis, with neutrophilic infiltration of alveolar septa and capillaries (endothelialitis and capillaritis) and microthrombosis 2-5 . This is followed by an exudative phase of diffuse alveolar damage (DAD), with fibrinous edema in the alveolar spaces, increased numbers of macrophages and epithelial multinucleated giant cells, hyaline membrane formation, and epithelial necrosis followed by type 2 pneumocyte hyperplasia. Additionally, vascular changes occur, including endothelial necrosis, hemorrhage, thrombosis of capillaries and small arteries, and vasculitis 4, 6 . In turn, the organizing stage of DAD, and the final fibrotic stage of DAD ensue which may include proliferation of myofibroblasts within the lung interstitium, and J o u r n a l P r e -p r o o f deposition of collagen leading to fibrosis. Squamous metaplasia has also been observed 2, 7 .

The emergent and widespread nature of this pandemic necessitated the rapid development of multiple animal models and biologic systems to study various aspects of pathogenesis, treatment, and prevention of disease. To date, reported animal models of COVID-19 pathology include human ACE2 transgenic mice [8] [9] [10] [11] , golden Syrian hamsters [11] [12] [13] [14] [15] [16] [17] , nonhuman primates 18, 19 , and ferrets 20, 21 ; recent comprehensive reviews of animal models of COVID-19 were provided by Zeiss et al., and Veenhuis and Zeiss, 2021 22, 23 . Each model species has advantages and limitations with respect to similarity to disease in humans, expense, and practicality. The hamster model offers several advantages over other animal models: it is a relatively small, immunocompetent animal that is susceptible to infection with varied SARS-CoV-2 clinical isolates and readily develops pulmonary disease. Specifically, hamsters consistently develop moderate to severe bronchointerstitial pneumonia characterized by acute inflammation, edema, and necrosis 2-4 days post SARS-CoV2 challenge, progressing to proliferative interstitial pneumonia with type II pneumocyte hyperplasia by 7 days post-challenge. Pulmonary lesions have been reported to resolve around 10-14 days post-inoculation with little to no evidence of residual damage [12] [13] [14] [15] [16] [17] 19, 24 .

Although several studies have provided an overview of pulmonary pathology during (2 male and 2 female) and 19 SARS-CoV-2-inoculated hamsters (10 male and 9 female) were euthanized at 28 DPI. Body weights were measured daily until 10 DPI, then on 14, 21, and 28 DPI.

Blood samples were collected at 0, 7, 14, 21, and 28 DPI depending on group. Terminal blood samples obtained via cardiac puncture were saved for serology and FACS analysis. At study endpoints, animals were euthanized with intraperitoneal sodium pentobarbital. A complete post-mortem examination with comprehensive tissue harvest (flash frozen and 10% NBF immersion fixed samples) was performed on all hamsters.

The animal procedures in this study were approved by the Institutional Animal Care and Use Committee at Johns Hopkins University and in accordance with the National Research Council's Guide for the Care and Use of Laboratory Animals (8 th edition) 27 .

The Johns Hopkins program of animal care and use is accredited by AAALAC international.

Infectious virus titers in the respiratory tissue homogenates were determined by the 50% tissue culture infectious dose (TCID50) assay 28 . Briefly, tissue homogenates were serially diluted 10-fold, transferred in sextuplicate into 96-well plates confluent with Vero-E6-TMPRSS2 cells (obtained from the Japan Institute of Infectious Diseases), incubated at 37 0 C for 4 days, and then stained with naphthol blue-black solution for visualization. Infectious viral titers (TCID50/mL) were determined by Reed and Muench method. For detection of SARS-CoV-2 genome copies, RNA was extracted from lungs using the Qiagen viral RNA extraction kit (Qiagen) and reverse transcriptase PCR J o u r n a l P r e -p r o o f (RTqPCR) was performed as previously described 29 . Viral data from a subset of these animals has been included in a report on humoral responses in this model 28 .

Standard necropsy procedures included gross examination of all major organs. After obtaining organ weights, samples were either frozen or immersion fixed in 10% neutralbuffered formalin. The lungs were weighed en bloc, and then the left lobe was removed at the level of the left bronchus. Formalin was gently infused into the left bronchus to inflate the left lobe, then the entire lobe was submerged in formalin. The right lung lobes were divided into different frozen sample collection tubes for preparing tissue homogenates and RNA extraction.

After immersion fixation in 10% neutral-buffered formalin for 72 hours, tissues were trimmed, processed, and embedded in paraffin. 5µm thick sections were mounted on glass slides and stained with hematoxylin and eosin (H&E). Histopathological analysis was performed independently by two veterinary pathologists (S.B. and K.M.) blinded to animal identification and infection status. Tissues evaluated included nasal cavity, trachea, lung (left lobe), esophagus, stomach, small intestine, cecum, large intestine, brain, heart, kidney, liver, gallbladder, spleen, adrenal gland, reproductive organs, urinary bladder, lymph nodes, salivary glands, bone, haired skin, skeletal muscle, bone marrow, and decalcified cross sections of the head.

In situ hybridization and immunohistochemistry DS9390 Leica Biosystem, Richmond, IL). Immunostaining was performed using the Bond RX automated system (Leica Biosystems, Richmond, IL). Positive immunostaining was visualized using DAB and RED, and slides were counterstained with hematoxylin.

Whole slides containing sections of the entire left lung lobe cut through the long axis were scanned at 20x magnification on the Zeiss Axio Scan.Z1 platform using automatic tissue detection with manual verification. Lung sections were analyzed using QuPath v. 0.2.2 (Supplemental Script S1). To measure Iba-1 and CD3 immunostaining, the create thresholder function was applied to detect levels of DAB above a threshold that was designated as positive within a given annotated area, or region of interest (ROI). The percent positive ROI was calculated using positive area quantitated by the thresholder divided by total area of the ROI. For SARS-CoV-2 ISH quantitation, the train pixel classifier tool was used. Within an ROI, annotations were created and designated as either positive or ignore, which allowed QuPath to correctly identify areas of positive staining. Percent positive ROI was calculated using positive area detected by the classifier divided by total area of the ROI.

To quantitate consolidation of lungs to include infiltrating inflammatory cells (macrophages, neutrophils, and lymphocytes), type II pneumocyte hyperplasia, necrotic J o u r n a l P r e -p r o o f cellular debris, and proteinaceous exudate while excluding artefactually collapsed or poorly insufflated regions (atelectasis), the QuPath wand tool was used to outline each scanned section of lung, creating an annotation. Superpixels were generated using the DoG superpixel segmentation function in QuPath. These detections were then selected, and intensity features were added. Next, areas within the ROI were annotated using multiple slides of infected and control animals that were designated as "Consolidation", "Non-consolidated", "Atelectasis" (i.e. artefactually collapsed or poorly insufflated regions), or "Ignore". This allowed the classifier to successfully detect areas of affected tissue, while ignoring areas that were unaffected, densely stained due to normal tissue architecture, or collapsed due to variable formalin infusion of the lungs. The consolidation classifier (AI classifier) was assembled using multiple iterations that were qualitatively assessed after each analysis by a veterinary anatomic pathologist. Percent consolidation was calculated using the number of superpixels identified as consolidated divided by the total number of superpixels detected for a given slide.

Freshly collected whole blood in EDTA was stained for FACS analysis with the limited antibodies available that cross-react in the hamster model at the initiation of the study. 

Statistical analyses were performed using GraphPad Prism version 7.04. One-way analysis of variance (ANOVA) was used to detect significant differences between groups of animals sampled at different time points post-inoculation. The two-sample ttest was used to evaluate differences between two groups. Infectious virus titers and J o u r n a l P r e -p r o o f viral RNA copies were log transformed and compared using two-way ANOVA with mixed-effects analysis followed by Bonferroni's multiple comparison test.

The most robust finding following SARS-CoV-2 inoculation was decreased body weight ( Figure 1A ). Animals inoculated with SARS-CoV-2 progressively lost body weight in the first week of infection until the 6 DPI nadir (-13.8% decline in group mean body weight from baseline; 19.3 % lower than control animal group mean at 6 DPI, P < 0.001) before gradually rebounding over the course of the following 3 weeks. At day 28 DPI, control and infected group body weights were not significantly different (P=0.095). Sex differences in body mass loss have been documented in hamsters infected with SARS-CoV-2, and those differences were explored previously 28 .

SARS-CoV-2-inoculated hamsters did not consistently develop clinical signs of respiratory disease; only mild nasal discharge or slight increased respiratory effort was observed intermittently in very few animals.

Peak infectious viral titers in the nasal turbinates, trachea, and lungs were present at 2 DPI, then decreased at 4 DPI ( Figure 2 ). The highest levels of infectious SARS-CoV-2 were found in nasal turbinates at 2 DPI (5.0 x 10 7 TCID50/mL); lung levels were highest at 2 DPI (7.33 x 10 6 TCID50). While infectious virus was cleared from the respiratory tract J o u r n a l P r e -p r o o f of most of the hamsters by 7 DPI, infectious virus was detected in the lungs of a single animal. No sex differences in viral load were detected in infected hamsters 28 .

On gross necropsy examination, lungs from both infected and control animals were indistinguishable, with variably mottled red to brown coloration randomly distributed in all lung lobes, suggesting that this change was due to perimortem procedures and not a reliable indicator of pathology related to SARS-CoV-2 infection. Two animals had adhesions between the lung lobes and the diaphragm; both were infected animals euthanized 7 DPI. Compared to uninfected control animals, average post-mortem lung weights were 50% higher in infected animals at 4 DPI and 105% higher at 7 DPI ( Figure   1B ; P = 0.014; P <0.0001, respectively, 2-way ANOVA multiple comparisons). All other tissues were unremarkable in both control and SARS-CoV-2-infected animals.

The nasal cavity contained eosinophilic proteinaceous exudate with abundant degenerate neutrophils in all infected animals (8/8) 

The nasal cavity and trachea morphology were unremarkable in all infected (8/8) and control (4/4) animals.

In infected animal lungs (Figure 3 

The nasal cavity and trachea morphology were unremarkable in all infected (8/8) and control (4/4) animals.

In infected animals, the lungs ( Figure 3 Immunostaining for pancytokeratin revealed that numerous atypical and multinucleated cells were immunopositive, indicating that these cells were epithelial, consistent with proliferative type II pneumocytes contributing to alveolar repair ( Figure 6 ). Double immunostaining demonstrated that both macrophages and proliferative epithelial cells were present within the densely cellular areas of the lungs of 7 DPI animals, confirming that inflammatory and reparative responses were contributing to the vast areas of consolidation at this time point.

QuPath was used for performing digital image analysis to quantitate the percentage of lung that was affected with inflammation and reparative processes in SARS-CoV2infected animals (Supplemental Figure S7) . The goal of this consolidation scoring approach was to encompass inflammatory cells (macrophages, neutrophils, and 

Minimal to mild multifocal foci of necrosis accompanied by neutrophils within the liver were occasionally observed in all groups and were considered a background lesion.

The bone marrow in all animals was densely cellular, with abundant myeloid cells including numerous band cells, as well as erythroid and megakaryocyte lineages. The spleen in all animals was comprised of predominantly red pulp, with no obvious signs of lymphoid depletion nor lymphoid hyperplasia. Abdominal lymph nodes occasionally contained germinal centers in control and infected animals. No significant changes were noted in the gastrointestinal tract, including the oral cavity, esophagus, small intestine, cecum, and colon. Kidneys in animals across all groups (29/45) had minimal protein and mineral within the tubules. Adrenal glands within hamsters of all groups had variable numbers of pigmented cells within the cortex, which has been reported to be a change in aged hamsters 30 . Other organs that were examined without significant changes on histopathology included: brain, heart, gallbladder, male and female reproductive organs, urinary bladder, salivary glands, bone, haired skin, skeletal muscle, and decalcified cross sections of the head. 15, 31 . Various studies consistently report increase in severity of inflammation up to 7 DPI, with variable specificity on the cell types involved, and include lymphocytes, neutrophils, and macrophages [12] [13] [14] [15] 31 . Inflammatory changes in the lungs are reported to resolve by 10-14 DPI, with the exception of some residual nonspecific inflammatory changes in aged hamsters [12] [13] [14] [15] [16] 31 . In this study, residual areas of type II pneumocyte hyperplasia were present in all infected animals at 14 and 28 DPI.

Pulmonary pathology in this model which emulates findings reported in humans include features of diffuse alveolar damage, intra-alveolar macrophage infiltration, and type II pneumocyte hyperplasia 32 . Diffuse alveolar damage was not a dominant aspect in this study but foci of septal necrosis and organized fibrinous exudate developed in some animals at early time points. Atypical proliferation of type II pneumocytes in the hamster model during the reparative phase of disease has been inconsistently reported but was a very consistent and prominent finding in this study 13 

Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study

The pulmonary pathology of COVID-19

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction

The evolution of pulmonary pathology in fatal COVID-19 disease: an autopsy study with clinical correlation

Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome : Results From a Prospective

Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study

SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function

SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory function

A Mouse Model of SARS-CoV-2 Infection and Pathogenesis

Evidence for SARS-CoV-2 Infection of Animal Hosts. Pathogens

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Age-dependent progression of SARS-CoV-2 infection in Syrian hamsters

Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters

Prüss H: A Therapeutic Nonself-reactive SARS-CoV-2 Antibody Protects from Lung

Respiratory disease in rhesus macaques inoculated with SARS-CoV-2

REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters

Infection and Rapid Transmission of SARS-CoV-2 in Ferrets

Animal models for COVID-19

Animal Models of COVID-19. I. Comparative Virology and Disease Pathogenesis

Animal Models of COVID-19 II

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

QuPath: Open source software for digital pathology image analysis. Sci Rep

Automated quantification of immunohistochemical staining of large animal brain tissue using qupath software

US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals: Guide for the care and use of laboratory animals

Sex differences in lung imaging and SARS-CoV-2 antibody responses in a COVID-19 golden Syrian hamster model. BioRxiv

Repeat COVID-19 Molecular Testing: Correlation of SARS-CoV-2 Culture with Molecular Assays and Cycle Thresholds

A histological and cytological study of the adrenal gland of the golden hamster (Cricetus auratus) in relation to age

Standardization of Reporting Criteria for Lung Pathology in SARS-CoV-2-infected Hamsters: What Matters?

A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression

Syrian hamsters (Mesocricetus auratus) oronasally inoculated with a Nipah virus isolate from Bangladesh or Malaysia develop similar respiratory tract lesions

The adaptive immune response does not influence hantavirus disease or persistence in the Syrian hamster

Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2

Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia

Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage

Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)